Post Reply
21-40 of 2523
Here is a concise summary of the key points from DISA Limited' s investment announcement:
### **Core Transaction**
- **What**: DISA' s subsidiary (ADH) acquires **50% stake** in Rheumatology Associates Pte. Ltd. (RA) for **S$5.5 million**.
- **Seller**: Dr. Yoon Kam Hon (unrelated to DISA). Post-acquisition, he retains 50% ownership and control of RA.
- **Payment Structure**:
- S$2.5M in DISA shares (250M new shares @ S$0.01/share, a 900% premium to market price).
- S$0.5M cash upfront.
- Deferred payments: S$1M (9 months) + S$1.5M (12 months), both with 5% annual interest.
- **Completion Date**: 28 July 2025 (subject to conditions).
### **Rationale**
- **Strategic Growth**: Aligns with DISA&rsquo s goal to expand in healthcare. RA is Singapore&rsquo s only heartland-based integrated rheumatology center (20+ years&rsquo track record).
- **Market Opportunity**: Targets aging population (25% aged 65+ by 2030), rising demand for arthritis/rheumatism care.
- **Synergy**: Integrates AI diagnostic tools from DISA&rsquo s subsidiary to enhance RA&rsquo s franchise scalability.
### **Key Commitments**
- Dr. Yoon appointed as RA&rsquo s Chief Medical Officer for &ge 10 years.
- Royalty fee: 5% of revenue from new clinics/therapy centers he helps establish.
### **Financial Impact**
- **Pro Forma Improvement**:
- Net Tangible Assets (NTA)/share: &uarr from S$0.013 to S$0.037.
- Loss Per Share (LPS): &darr from (S$0.019) to (S$0.011).
- **Funding**: Internal resources + new shares (no shareholder approval needed within existing mandate).
### **Regulatory Status**
- Classified as a **" discloseable transaction" ** under SGX Catalist Rules (no shareholder approval required).
- Relative figures under Rule 1006:
- Consideration vs. market cap: **39.7%**.
- New shares issued: **1.8%** of enlarged capital.
### **Conditions & Risks**
- **Conditions Precedent**: Due diligence, SGX listing approval, consents, etc. (deadline: 29 Aug 2025).
- **Caution**: Completion subject to conditions investors advised to exercise caution.
### **Other Details**
- **Finder&rsquo s Fee**: S$220,000 (4% of consideration) paid to Dr. Yoon&rsquo s sibling.
- **No Conflicts**: Directors/shareholders have no direct/indirect interest in the deal.
**Bottom Line**: DISA gains foothold in specialized rheumatology care via a structured acquisition, leveraging RA&rsquo s established presence and demographic tailwinds, with potential for AI-driven expansion.
sklong138 ( Date: 08-Jul-2025 10:35) Posted:
|
nta 0.00001 ct...100x even at 0.001 trading...how ah?
eddyeddy ( Date: 13-Jun-2025 15:00) Posted:
|
RECAP
sklong138 ( Date: 25-Jun-2025 16:16) Posted:
|
did DISA just made a u-turn 
I remember you got some micro pennies suspended including SY.. and also your QT vascular dropped until pants drop... ok lah, at least now you learn to buy at 0.001 haha, lower risk.. perhaps burnt until chow tar liao..
Best time to buy at 0.001 , don' t wait to buy at 0.005 like capallianz.
This is very likely to be the next rotational play. Huat Ar.
Same as the way you hold shenyao
sklong138 ( Date: 25-Jun-2025 14:51) Posted:
|
Full excess allotment with free warrants :)
This might be the next rotational play. But you must have the holding power and patience.
Interesting warrant sub price...
Let's see how the spin master make it profitable..
bishalnb ( Date: 09-Jun-2025 20:47) Posted:
|
Shareholders fund all go to pay those in Disa , CEO and brother take about 1.8m one year. Biz worst than provision store.
. Overview
1. DiSa Limited focuses on combating return fraud in the retail industry using its 3S Smart Barcode (serialization technology) and RFID integration. The company' s Shared Savings Program (SSP) offers a " no cure, no pay" model, where DiSa earns a share of retailers' savings from prevented fraudulent returns.
2. Key Technologies
3S Smart Barcode: Combines UPC with a unique serial number (" DiSa Number" ) to track items individually, blocking invalid returns at Point-of-Sale (POS).
Serialized RFID Tags: Integrates 3S technology into RFID tags, enabling dual functionality:
Real-time inventory tracking (RFID).
Fraud prevention (serialization).
3. Market Shift and Adoption
2017&ndash 2021: Slow adoption due to lack of retailer mandates and vendor cost burdens.
Post-2022: RFID mandates by major U.S. retailers (e.g., apparel, electronics) accelerated adoption. DiSa partnered with RFID printers (e.g., Avery Dennison) to provide free serialized RFID tags to vendors.
Current Progress:
50% of SKUs at a major retailer use serialized RFID tags.
$159M in fraud savings (avg. $20M/year).
4. Shared Savings Program (SSP) Benefits
Retailers: No upfront cost pay DiSa only when fraud is prevented.
Vendors: Free serialized RFID tags reduced return rates (30&ndash 40% avg.).
RFID Printers: Grow market share by distributing DiSa-enabled tags.
5. Industry Context
2024 U.S. Retail Data:
$5.19T total sales $685B returns (13.21%) $103B fraudulent returns (15.14%).
Common Fraud Types: Wardrobing (60%), stolen tender (55%), counterfeit receipts (48%).
6. Next Steps
Expand SSP to more product categories.
Target high-fraud-risk SKUs.
Scale via RFID partnerships.
7. Cautionary Notes
Forward-looking statements involve risks (e.g., adoption challenges).
Investors should evaluate factors carefully.
Conclusion
DiSa&rsquo s SSP leverages RFID mandates to scale serialization, creating a win-win-win for retailers, vendors, and itself by reducing fraud costs with no upfront investment.
i wonder if it' s worth buying
bishalnb ( Date: 09-Jun-2025 19:10) Posted:
|
but is this still good ? -
The Exercise Price will be tiered at the following rates: (a) S$0.005 per Warrant Share during the period from the date of issue of the Warrants and up to the date immediately preceding the 1st anniversary of the date of issue of the Warrants (&ldquo 1st Exercise Period&rdquo ) and (b) S$0.010 per Warrant Share during the period from and including the 1st anniversary of the date of issue of the Warrants and up to the date immediately preceding the 18th month from the date of issue of the Warrants (&ldquo 2nd Exercise Period&rdquo )
The Exercise Price will be tiered at the following rates: (a) S$0.005 per Warrant Share during the period from the date of issue of the Warrants and up to the date immediately preceding the 1st anniversary of the date of issue of the Warrants (&ldquo 1st Exercise Period&rdquo ) and (b) S$0.010 per Warrant Share during the period from and including the 1st anniversary of the date of issue of the Warrants and up to the date immediately preceding the 18th month from the date of issue of the Warrants (&ldquo 2nd Exercise Period&rdquo )
Because the rights shares comes with free warrants
bishalnb ( Date: 09-Jun-2025 19:10) Posted:
|
Can someone please explain, why should i subscribe to rights at $0.001 when i can buy the share from the market at $0.001?
Thanks for your clarification.
SmallSmall ( Date: 05-Jun-2025 08:26) Posted:
|
Non-renounceable. No rights trading
sklong138 ( Date: 04-Jun-2025 07:45) Posted:
|
DATE OF SELLING RIGHTS IS 24 JUN 2025 AT 9 AM
DATE OF SELLING WARRANTS IS 25 JUN 2025 AT 9 AM